Effects of probiotics for the treatment of bacterial vaginosis in adult women: A meta-analysis of randomized clinical trials

Archives of Gynecology and Obstetrics

Volumn 289, Issue 6, 2014, Pages 1225-1234

  Huang, Haohai ^a   Song, Lijun ^a   Zhao, Wenchang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Bacterial vaginosis; Meta analysis; Probiotics

Indexed keywords

ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ADULT; AMSEL CRITERIA; ARTICLE; CURE RATE; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; ETHNIC GROUP; EUROPEAN; EVALUATION STUDY; FEMALE; FOLLOW UP; GENERAL PATHOLOGICAL PARAMETERS; HUMAN; JADAD SCORE; META ANALYSIS; NAUSEA; NUGENT SCORE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; SYSTEMATIC REVIEW; VAGINA DISEASE; VAGINAL PRURITUS; VAGINAL SORENESS; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VAGINOSIS, BACTERIAL;

EID: 84905164121     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3117-0     Document Type: Article

References (47)

1. Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE (2007) The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34(11):864-869. doi:10.1097/OLQ.0b013e318074e565 (Pubitemid 350287499)
2. Kenyon C, Colebunders R, Crucitti T (2013) The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol. doi:10.1016/j.ajog.2013.05.006
3. Ness RB, Kip KE, Hillier SL, Soper DE, Stamm CA, Sweet RL, Rice P, Richter HE (2005) A cluster analysis of bacterial vaginosis- associated microflora and pelvic inflammatory disease. Am J Epidemiol 162(6):585-590. doi:10.1093/aje/kwi243 (Pubitemid 41253257)
4. Larsson PG, Bergstrom M, Forsum U, Jacobsson B, Strand A, Wolner-Hanssen P (2005) Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS 113(4):233-245. doi:10.1111/j.1600-0463. 2005.apm-01.x (Pubitemid 40676804)
5. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV et al (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med 333(26):1737-1742. doi:10.1056/nejm199512283332604
6. Cherpes TL, Hillier SL, Meyn LA, Busch JL, Krohn MA (2008) A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxideproducing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis 35(1):78-83. doi:10.1097/ OLQ.0b013e318156a5d0
7. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS (London, England) 22(12):1493-1501. doi:10.1097/QAD.0b013e3283021a37
8. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL (2003) Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis 36(5):663-668. doi:10.1086/367658 (Pubitemid 36259574)
9. Gillet E, Meys JF, Verstraelen H, Bosire C, De Sutter P, Temmerman M, Broeck DV (2011) Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis 11:10. doi:10.1186/1471-2334- 11-10
10. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK (2006) High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193(11):1478-1486. doi:10.1086/ 503780
11. Oduyebo OO, Anorlu RI, Ogunsola FT (2009) The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 3:CD006055. doi:10.1002/14651858.CD006055.pub2
12. Joesoef MR, Schmid GP, Hillier SL (1999) Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 28(Suppl 1):S57-S65. doi:10.1086/ 514725
13. Swidsinski A, Mendling W, Loening-Baucke V, Ladhoff A, Swidsinski S, Hale LP, Lochs H (2005) Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106(5 Pt 1):1013-1023. doi:10.1097/01.AOG.0000183594.45524.d2 (Pubitemid 41532908)
14. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Investig 112(10):1466-1477. doi:10.1172/jci20365 (Pubitemid 38056271)
15. Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect 4(3):319-324 (Pubitemid 34293637)
16. Reid G, Burton J, Devillard E (2004) The rationale for probiotics in female urogenital healthcare. MedGenMed 6(1):49
17. Saunders S, Bocking A, Challis J, Reid G (2007) Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Colloids Surf B 55(2):138-142. doi:10.1016/j.colsurfb.2006.11.040
18. McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, Fu J, Abbas A, Dang T, Miller W, Reid G (2011) Disruption of urogenital biofilms by lactobacilli. Colloids Surf B 86(1):58-64. doi:10.1016/j.colsurfb.2011.03.016
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. doi:10.1371/journal.pmed.1000100
20. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74(1):14-22 (Pubitemid 13221599)
21. Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29(2):297-301
22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1-12 (Pubitemid 26120810)
23. Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 135(11):982-989 (Pubitemid 33131619)
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ (Clinical research ed) 327(7414):557-560. doi:10.1136/bmj.327.7414.557 (Pubitemid 37088507)
25. Hallen A, Jarstrand C, Pahlson C (1992) Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 19(3):146-148
26. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, Kaiser RR (1996) Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittelforschung 46(1):68-73
27. Eriksson K, Carlsson B, Forsum U, Larsson PG (2005) A doubleblind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereo 85(1):42-46. doi:10.1080/ 00015550410022249
28. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, Reid G (2006) Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 8(6):1450-1454. doi:10.1016/j.micinf.2006.01.003 (Pubitemid 43903313)
29. Petricevic L, Witt A (2008) The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 115(11):1369- 1374. doi:10.1111/j.1471-0528.2008. 01882.x
30. Marcone V, Calzolari E, Bertini M (2008) Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 31(3):429-433
31. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S (2008) Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 8:3. doi:10.1186/1472-6874-8-3
32. Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, Midulla C (2009) Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 15(1):67-74. doi:10.1111/ j.1469-0691.2008.02112.x
33. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Gomes BC, De Martinis EC, Reid G (2009) Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol 55(2):133-138. doi:10.1139/w08-102
34. Ya W, Reifer C, LE Miller (2010) Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 203(2):120 e121-120 e126. doi:10.1016/j.ajog.2010.05.023
35. Marcone V, Rocca G, Lichtner M, Calzolari E (2010) Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Gynaecol Obstet 110(3):223-226. doi:10.1016/j.ijgo.2010.04.025
36. Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, Fehler G, Morrow A, Walker S, Vodstrcil LA, Fairley CK (2012) Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS One 7(4):e34540. doi:10.1371/journal.pone.0034540
37. Reid G, Dols J, Miller W (2009) Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care 12(6):583-587. doi:10.1097/MCO. 0b013e328331b611
38. Reid G (2008) Probiotic Lactobacilli for urogenital health in women. J Clin Gastroenterol 42(Suppl 3 Pt 2):S234-S236. doi:10.1097/MCG.0b013e31817f1298
39. Falagas M, Betsi GI, Athanasiou S (2007) Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect 13(7):657-664 (Pubitemid 46909341)
40. Matu MN, Orinda GO, Njagi EN, Cohen CR, Bukusi EA (2010) In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe 16(3):210-215. doi:10.1016/j.anaerobe.2009. 11.002
41. Senok AC, Verstraelen H, Temmerman M, Botta GA (2009) Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev 4:CD006289. doi:10.1002/14651858.CD006289.pub2
42. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G (2006) Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 8(12-13):2772-2776. doi:10.1016/j.micinf.2006.08.008 (Pubitemid 44692555)
43. MacPhee RA, Hummelen R, Bisanz JE, Miller WL, Reid G (2010) Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother 11(18):2985- 2995. doi:10.1517/14656566.2010.512004
44. Mastromarino P, Vitali B, Mosca L (2013) Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol 36(3):229-238
45. Barrons R, Tassone D (2008) Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review. Clin Ther 30(3):453-468. doi:10.1016/j.clinthera.2008.03.013 (Pubitemid 351492532)
46. Shalev E, Battino S, Weiner E, Colodner R, Keness Y (1996) Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 5(10): 593-596 (Pubitemid 126445148)
47. Strus M, Chmielarczyk A, Kochan P, Adamski P, Chelmicki Z, Chelmicki A, Palucha A, Heczko PB (2012) Studies on the effects of probiotic Lactobacillus mixture given orally on vaginal and rectal colonization and on parameters of vaginal health in women with intermediate vaginal flora. Eur J Obstet Gynecol Reprod Biol 163(2):210-215. doi:10.1016/j.ejogrb.2012.05.001